Skip to content

Predisposition to Infectious Endocarditis

Gender Study on Predisposition to Infectious Endocarditis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03979261
Enrollment
450
Registered
2019-06-07
Start date
2019-07-01
Completion date
2022-07-01
Last updated
2019-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective Endocarditis

Brief summary

To evaluate the gender-related elements, a first step will be to analyze the impact of sex ratio on different parameters such as age in endocarditis and the type of underlying valvulopathy and other associated comorbidities.

Detailed description

Numerous epidemiological studies have made it possible to highlight the impact of the genus on the occurrence and natural evolution of numerous valvulopathies. Severe valve leakage occurs more frequently in men. This association is also observed in patients with aortic bicuspid infarction where infective endocarditis (IE) is 3 times more common in men with a sex ratio of 9 to 2 to 1. Male sex is also a risk factor of AEs in the admission score used in initial patient management used to stratify the risk of AE and start probabilistic antibiotic therapy. Several hypotheses were evoked and none made it possible to understand the impact of sex on the risk of IE. The transcriptome study of IE patients revealed 2 potential biomarkers. S100A11 (S100 calcium binding protein A11) is a diagnostic marker and AQP9 (Aquaporin 9 gene) a poor prognostic factor in patients with AE. Coxiella burnetii AE is more common and more severe in humans. A study in the C57 / BL6 mouse demonstrated the role of 17 beta-estradiol in decreasing bacterial load and granuloma formation in female mice. The hypothesis formulated is that sex hormones play a role in the natural history of IS. This hypothesis was confirmed at the transcriptome level in mice and allowed to identify transcriptomic signatures according to sex; male mice with a more marked inflammatory response to C. burnetii. In order to evaluate the gender-related elements, an initial work will be to analyze the impact of sex ratio on different parameters such as age in endocarditis and the type of underlying valvulopathy and other associated comorbidities. The second part of the project will study (i) the transcriptional profile of the native valves removed in patients with endocarditis-free valvulopathy in male and female subjects (ii) the transcriptional profile of native valves removed during endocarditis in matching sex underlying valvulopathy and microorganism. This will evaluate a possible difference in susceptibility to endocardial fixation. (iii) the transcriptional profile of PBMCs (circulating mononuclear cells) in this same patient, which will make it possible to study the transcriptional profile of the circulating genes and to evaluate the possible difference in predisposition to endocardial fixation. Finally, the third part will focus on the histological analysis of the valves collected to study the differences between man and woman (local inflammatory reaction, cell type found).

Interventions

DIAGNOSTIC_TESTevolution of sex ratio according to age

Histological study of the collected valves to study the differences according to the sex of the inflammatory reaction and the cellular type found.

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient with infectious endocarditis * Patient with valvulopathy or infective endocarditis requiring cardiac surgery as part of routine care. * Major patient * Patient informed of the study and having expressed no opposition to participate in the study. * Patient affiliated to a social security scheme.

Exclusion criteria

* Minor patient * Pregnant or nursing patient. * Patient deprived of liberty or under judicial decision. * Major patient under tutorship or curatorship. * Patient not agreeing to participate

Design outcomes

Primary

MeasureTime frame
Evolution of sex ratio as a function of age and underlying pathologies (comorbidities and valvulopathies)36 months

Secondary

MeasureTime frameDescription
transcriptional profile by microarray36 monthsrate of indigenous valves removed in patients with valvulopathy without endocarditis by gender

Countries

France

Contacts

Primary ContactDidier RAOULT, IP
didier.raoult@ap-hm.fr04 13 73 20 5

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026